Eiger Biopharmaceuticals, Inc. (EIGR) Files Form 4 Insider Buying : James H Welch Buys 2,500 Shares

Eiger Biopharmaceuticals, Inc. (EIGR): James H Welch , CFO of Eiger Biopharmaceuticals, Inc. purchased 2,500 shares on Jun 20, 2016. The Insider buying transaction was reported by the company on Jun 22, 2016 to the Securities and Exchange Commission. The shares were purchased at $19.80 per share for a total value of $49,489.60 , the company said in a SEC Form 4 Filing.

Company has been under the radar of several Street Analysts.Eiger Biopharmaceuticals, Inc. is Initiated by Wedbush to Outperform and the brokerage firm has set the Price Target at $36. The Rating was issued on Jun 2, 2016.Eiger Biopharmaceuticals, Inc. is Initiated by Jefferies to Buy and the brokerage firm has set the Price Target at $35. The Rating was issued on Apr 7, 2016.

Leave a Reply

Eiger Biopharmaceuticals, Inc. - Is it time to Sell?

Top Brokerage Firms are advising their investors on Eiger Biopharmaceuticals, Inc.. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.